Behavioral effects of triadimefon in zebrafish are associated with alterations of the dopaminergic and serotonergic pathways.


Journal

Progress in neuro-psychopharmacology & biological psychiatry
ISSN: 1878-4216
Titre abrégé: Prog Neuropsychopharmacol Biol Psychiatry
Pays: England
ID NLM: 8211617

Informations de publication

Date de publication:
08 06 2019
Historique:
received: 30 08 2018
revised: 14 12 2018
accepted: 19 12 2018
pubmed: 30 12 2018
medline: 30 6 2019
entrez: 30 12 2018
Statut: ppublish

Résumé

Triadimefon (TDF) is a triazole fungicide extensively used in agriculture that has been found as a pollutant in numerous water sources. In mammals, it inhibits monoamine uptake through binding to the dopamine transporter, with a mechanism of action similar to cocaine, resulting in higher levels of dopamine at the synapse. Dopamine is a neurotransmitter involved in a broad spectrum of processes such as locomotion, cognition, reward, and mental disorders. In this work we have studied, for the first time, the effects of TDF on behavior of both larval and adult zebrafish and its connection with changes in the dopaminergic and serotonergic systems. We evaluated the acute exposure of 5 dpf larvae to different concentrations of TDF, ranging from 5 mg/L to 35 mg/L. The lowest concentration does not alter neither locomotor activity nor dopamine levels but produced changes in the expression of two genes, tyrosine hydroxylase 1 (th1) and dopamine transporter (dat). Besides, it induced a reduction in extracellular serotonin and had an anxiolytic-like effect, supported by a decrease in cortisol production. On the other hand, a high concentration of TDF produced a dose-dependent reduction in locomotion, which was reversed or enhanced by D1 (SCH-23390) or D2 (Haloperidol) dopamine receptor antagonists, respectively. Using in vivo electrochemistry, we show that these changes could be associated with higher levels of dopamine in the brain. Thus, in adult zebrafish, though not in larvae, TDF exposure increases locomotor activity, anxiety and aggressiveness, which coincides with the behaviors observed in mammals.

Identifiants

pubmed: 30593828
pii: S0278-5846(18)30696-1
doi: 10.1016/j.pnpbp.2018.12.012
pii:
doi:

Substances chimiques

Benzazepines 0
Dopamine Antagonists 0
SCH 23390 0
Triazoles 0
Water Pollutants 0
triadimefon 1HW039CJF0
Serotonin 333DO1RDJY
Haloperidol J6292F8L3D
Dopamine VTD58H1Z2X
Hydrocortisone WI4X0X7BPJ

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

118-126

Informations de copyright

Copyright © 2018. Published by Elsevier Inc.

Auteurs

Susana Paredes-Zúñiga (S)

FONDAP Center for Genome Regulation, Faculty of Science, University of Chile, Santiago, Chile.

Nils Trost (N)

FONDAP Center for Genome Regulation, Faculty of Science, University of Chile, Santiago, Chile; Center for Organismal Studies, University of Heidelberg, Heidelberg, Germany.

Javiera F De la Paz (JF)

FONDAP Center for Genome Regulation, Faculty of Science, University of Chile, Santiago, Chile.

Julio Alcayaga (J)

Departamento de Biología, Centro de Fisiología Celular, Facultad de Ciencias, Universidad de Chile, Santiago, Chile. Electronic address: jalcayag@uchile.cl.

Miguel L Allende (ML)

FONDAP Center for Genome Regulation, Faculty of Science, University of Chile, Santiago, Chile. Electronic address: mallende@uchile.cl.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH